1. Home
  2. DERM vs MNSB Comparison

DERM vs MNSB Comparison

Compare DERM & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • MNSB
  • Stock Information
  • Founded
  • DERM 2014
  • MNSB 2003
  • Country
  • DERM United States
  • MNSB United States
  • Employees
  • DERM N/A
  • MNSB N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • MNSB Major Banks
  • Sector
  • DERM Health Care
  • MNSB Finance
  • Exchange
  • DERM Nasdaq
  • MNSB Nasdaq
  • Market Cap
  • DERM 190.7M
  • MNSB 170.1M
  • IPO Year
  • DERM 2021
  • MNSB N/A
  • Fundamental
  • Price
  • DERM $7.54
  • MNSB $19.96
  • Analyst Decision
  • DERM Strong Buy
  • MNSB
  • Analyst Count
  • DERM 3
  • MNSB 0
  • Target Price
  • DERM $12.67
  • MNSB N/A
  • AVG Volume (30 Days)
  • DERM 92.2K
  • MNSB 37.1K
  • Earning Date
  • DERM 11-11-2025
  • MNSB 10-27-2025
  • Dividend Yield
  • DERM N/A
  • MNSB 2.01%
  • EPS Growth
  • DERM N/A
  • MNSB N/A
  • EPS
  • DERM N/A
  • MNSB N/A
  • Revenue
  • DERM $56,397,000.00
  • MNSB $64,604,000.00
  • Revenue This Year
  • DERM $26.25
  • MNSB $23.19
  • Revenue Next Year
  • DERM $52.96
  • MNSB $2.92
  • P/E Ratio
  • DERM N/A
  • MNSB N/A
  • Revenue Growth
  • DERM N/A
  • MNSB N/A
  • 52 Week Low
  • DERM $3.54
  • MNSB $15.00
  • 52 Week High
  • DERM $8.90
  • MNSB $22.98
  • Technical
  • Relative Strength Index (RSI)
  • DERM 59.93
  • MNSB 29.60
  • Support Level
  • DERM $6.85
  • MNSB $20.07
  • Resistance Level
  • DERM $7.45
  • MNSB $20.52
  • Average True Range (ATR)
  • DERM 0.30
  • MNSB 0.41
  • MACD
  • DERM 0.04
  • MNSB -0.17
  • Stochastic Oscillator
  • DERM 100.00
  • MNSB 0.00

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: